Role of strain differences on host resistance and the transcriptional response of macrophages to infection with Yersinia enterocolitica

Physiological Genomics

Volumn 25, Issue 1, 2006, Pages 75-84

  Van Erp, Katrin ^a   Dach, Kristina ^a   Koch, Isabel ^a   Heesemann, Jürgen ^a   Hoffmann, Reinhard ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bacterial infection; Balb c; C57BL 6; Host response

Indexed keywords

CHEMOKINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GAMMA INTERFERON; HOX PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR POU; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; BINDING SITE; BONE MARROW; CELL ACTIVATION; CONTROLLED STUDY; CYTOSKELETON; DNA FLANKING REGION; GENE EXPRESSION; GENE FUNCTION; GENE SEQUENCE; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOMICS; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOREGULATION; INHIBITION KINETICS; LYMPHOCYTE; MACROPHAGE FUNCTION; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION; YERSINIA ENTEROCOLITICA; YERSINIOSIS;

ANIMALS; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INTERFERON TYPE II; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; SPECIES SPECIFICITY; TIME FACTORS; TRANSCRIPTION, GENETIC; YERSINIA ENTEROCOLITICA; YERSINIA INFECTIONS;

ANIMALIA; BACTERIA (MICROORGANISMS); YERSINIA; YERSINIA ENTEROCOLITICA;

EID: 33645788347     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00188.2005     Document Type: Article

References (56)

1. Aepfelbacher M and Heesemann J. Modulation of Rho GTPases and the actin cytoskeleton by Yersinia outer proteins (Yops). Int J Med Microbiol 291: 269-276, 2001.
2. Aepfelbacher M, Zumbihl R, Ruckdeschel K, Jacobi CA, Barz C, and Heesemann J. The tranquilizing injection of Yersinia proteins: a pathogen's strategy to resist host defense. Biol Chem 380: 795-802, 1999.
3. Andersen B and Rosenfeld MG. POU domain factors in the neuroendocrine system: lessons from developmental biology provide insights into human disease. Endocr Rev 22: 2-35, 2001.
4. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, and Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29, 2000.
5. Autenrieth IB, Beer M, Bohn E, Kaufmann SH, and Heesemann J. Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect Immun 62: 2590-2599, 1994.
6. Benjamini Y and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B 57: 289-300, 1995.
7. Bohn E and Autenrieth IB. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells. J Immunol 156: 1458-1468, 1996.
8. Bohn E, Heesemann J, Ehlers S, and Autenrieth IB. Early gamma interferon mRNA expression is associated with resistance of mice against Yersinia enterocolitica. Infect Immun 62: 3027-3032, 1994.
9. Bohn E, Muller S, Lauber J, Geffers R, Speer N, Spieth C, Krejci J, Manncke B, Buer J, Zell A, and Autenrieth IB. Gene expression patterns of epithelial cells modulated by pathogenicity factors of Yersinia enterocolitica. Cell Microbiol 6: 129-141, 2004.
10. Bohn E, Schmitt E, Bielfeldt C, Noll A, Schulte R, and Autenrieth IB. Ambiguous role of interleukin-12 in Yersinia enterocolitica infection in susceptible and resistant mouse strains. Infect Immun 66: 2213-2220, 1998.
11. Bouchon A, Cella M, Grierson HL, Cohen JI, and Colonna M. Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family. J Immunol 167: 5517-5521, 2001.
12. Boulon S, Dantonel JC, Binet V, Vie A, Blanchard JM, Hipskind RA, and Philips A. Oct-1 potentiates CREB-driven cyclin D1 promoter activation via a phospho-CREB- and CREB binding protein-independent mechanism. Mol Cell Biol 22: 7769-7779, 2002.
13. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, and Werner T. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21: 2933-2942, 2005.
14. Chaussabel D, Semnani RT, McDowell MA, Sacks D, Sher A, and Nutman TB. Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood 102: 672-681, 2003.
15. Cornelis GR. The Yersinia Ysc-Yop 'type III' weaponry. Nat Rev Mol Cell Biol 3: 742-752, 2002.
16. Cornelis GR, Boland A, Boyd AP, Geuijen C, Iriarte M, Neyt C, Sory MP, and Stainier I. The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev 62: 1315-1352, 1998.
17. Cox D, Berg JS, Cammer M, Chinegwundoh JO, Dale BM, Cheney RE, and Greenberg S. Myosin X is a downstream effector of PI(3)K during phagocytosis. Nat Cell Biol 4: 469-477, 2002.
18. Ehrt S, Schnappinger D, Bekiranov S, Drenkow J, Shi S, Gingeras TR, Gaasterland T, Schoolnik G, and Nathan C. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J Exp Med 194: 1123-1140, 2001.
19. Eisen MB, Spellman PT, Brown PO, and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863-14868, 1998.
20. Ericsson J, Usheva A, and Edwards PA. YY1 is a negative regulator of transcription of three sterol regulatory element-binding protein-responsive genes. J Biol Chem 274: 14508-14513, 1999.
21. Fu AK, Fu WY, Ng AK, Chien WW, Ng YP, Wang JH, and Ip NY. Cyclin-dependent kinase 5 phosphorylates signal transducer and activator of transcription 3 and regulates its transcriptional activity. Proc Natl Acad Sci USA 101: 6728-6733, 2004.
22. Fujikawa K, Inoue Y, Sakai M, Koyama Y, Nishi S, Funada R, Alt FW, and Swat W. Vav3 is regulated during the cell cycle and effects cell division. Proc Natl Acad Sci USA 99: 4313-4318, 2002.
23. Gobert AP, Cheng Y, Akhtar M, Mersey BD, Blumberg DR, Cross RK, Chaturvedi R, Drachenberg CB, Boucher JL, Hacker A, Casero RA Jr, and Wilson KT. Protective role of arginase in a mouse model of colitis. J Immunol 173: 2109-2117, 2004.
24. Hamid N, Gustavsson A, Andersson K, McGee K, Persson C, Rudd CE, and Fallman M. YopH dephosphorylates Cas and Fyn-binding protein in macrophages. Microb Pathog 27: 231-242, 1999.
25. Hancock GE, Schaedler RW, and MacDonald TT. Yersinia enterocolitica infection in resistant and susceptible strains of mice. Infect Immun 53: 26-31, 1986.
26. Hancock GE, Schaedler RW, and MacDonald TT. Multigenic control of resistance to Yersinia enterocolitica in inbred strains of mice. Infect Immun 56: 532-533, 1988.
27. Harada N, Nakayama M, Nakano H, Fukuchi Y, Yagita H, and Okumura K. Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells. Biochem Biophys Res Commun 299: 488-493, 2002.
28. Heath H, Qin S, Rao P, Wu L, LaRosa G, Kassam N, Ponath PD, and Mackay CR. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest 99: 178-184, 1997.
29. Heesemann J and Laufs R. Construction of a mobilizable Yersinia enterocolitica virulence plasmid. J Bacteriol 155: 761-767, 1983.
30. Hoffmann R, Van Erp K, Trulzsch K, and Heesemann J. Transcriptional responses of murine macrophages to infection with Yersinia enterocolitica. Cell Microbiol 6: 377-390, 2004.
31. Hombria JC and Lovegrove B. Beyond homeosis - HOX function in morphogenesis and organogenesis. Differentiation 71: 461-476, 2003.
32. Kataoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M, Burns K, Hahne M, Kennedy N, Kovacsovics M, and Tschopp J. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol 10: 640-648, 2000.
33. Kutzleb C, Sanders G, Yamamoto R, Wang X, Lichte B, Petrasch-Parwez E, and Kilimann MW. Paralemmin, a prenyl-palmitoyl-anchored phosphoprotein abundant in neurons and implicated in plasma membrane dynamics and cell process formation. J Cell Biol 143: 795-813, 1998.
34. Li C and Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98: 31-36, 2001.
35. Li C and Wong WH. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol 2: research0032.1- 0032.11, 2001.
36. Liu G, Loraine AE, Shigeta R, Cline M, Cheng J, Valmeekam V, Sun S, Kulp D, and Siani-Rose MA. NetAffx: Affymetrix probesets and annotations. Nucleic Acids Res 31: 82-86, 2003.
37. Mayr B and Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2: 599-609, 2001.
38. Meylan E, Martinon F, Thome M, Gschwendt M, and Tschopp J. RIP4 (DIK/PKK), a novel member of the RIP kinase family, activates NF-kappa B and is processed during apoptosis. EMBO Rep 3: 1201-1208, 2002.
39. Muto A, Ruland J, McAllister-Lucas LM, Lucas PC, Yamaoka S, Chen FF, Lin A, Mak TW, Nunez G, and Inohara N. Protein kinase C-associated kinase (PKK) mediates Bcl10-independent NF-kappa B activation induced by phorbol ester. J Biol Chem 277: 31871-31876, 2002.
40. Nau GJ, Richmond JF, Schlesinger A, Jennings EG, Lander ES, and Young RA. Human macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci USA 99: 1503-1508, 2002.
41. Noti JD, Johnson AK, and Dillon JD. The leukocyte integrin gene CD11d is repressed by gut-enriched Kruppel-like factor 4 in myeloid cells. J Biol Chem 2004.
42. Ogata H, Su I, Miyake K, Nagai Y, Akashi S, Mecklenbrauker I, Rajewsky K, Kimoto M, and Tarakhovsky A. The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J Exp Med 192: 23-29, 2000.
43. Owhashi M, Taoka Y, Ishii K, Nakazawa S, Uemura H, and Kambara H. Identification of a ubiquitin family protein as a novel neutrophil chemotactic factor. Biochem Biophys Res Commun 309: 533-539, 2003.
44. Pruitt SC, Bussman A, Maslov AY, Natoli TA, and Heinaman R. Hox/Pbx and Brn binding sites mediate Pax3 expression in vitro and in vivo. Gene Expr Patterns 4: 671-685, 2004.
45. Ruckdeschel K, Harb S, Roggenkamp A, Hornef M, Zumbihl R, Kohler S, Heesemann J, and Rouot B. Yersinia enterocolitica impairs activation of transcription factor NF-kappaB: involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis factor alpha production. J Exp Med 187: 1069-1079, 1998.
46. 2-terminal kinase. Correlation with its inhibitory effect on tumor necrosis factor-alpha production. J Biol Chem 272: 15920-15927, 1997.
47. Ruckdeschel K, Mannel O, Richter K, Jacobi CA, Trulzsch K, Rouot B, and Heesemann J. Yersinia outer protein P of Yersinia enterocolitica simultaneously blocks the nuclear factor-kappa B pathway and exploits lipopolysaccharide signaling to trigger apoptosis in macrophages. J Immunol 166: 1823-1831, 2001.
48. Ruckdeschel K, Pfaffinger G, Haase R, Sing A, Weighardt H, Hacker G, Holzmann B, and Heesemann J. Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages. J Immunol 173: 3320-3328, 2004.
49. Ruckdeschel K, Roggenkamp A, Lafont V, Mangeat P, Heesemann J, and Rouot B. Interaction of Yersinia enterocolitica with macrophages leads to macrophage cell death through apoptosis. Infect Immun 65: 4813-4821, 1997.
50. Sauvonnet N, Pradet-Balade B, Garcia-Sanz JA, and Cornelis GR. Regulation of mRNA expression in macrophages after Yersinia enterocolitica infection. Role of different Yop effectors. J Biol Chem 277: 25133-25142, 2002.
51. Senaldi G, Varnum BC, Sarmiento U, Starnes C, Lile J, Scully S, Guo J, Elliott G, McNinch J, Shaklee CL, Freeman D, Manu F, Simonet WS, Boone T, and Chang MS. Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family. Proc Natl Acad Sci USA 96: 11458-11463, 1999.
52. Trulzsch K, Roggenkamp A, Aepfelbacher M, Wilharm G, Ruckdeschel K, and Heesemann J. Analysis of chaperone-dependent Yop secretion/translocation and effector function using a mini-virulence plasmid of Yersinia enterocolitica. Int J Med Microbiol 293: 167-177, 2003.
53. Tusher VG, Tibshirani R, and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001.
54. Weill L, Shestakova E, and Bonnefoy E. Transcription factor YY1 binds to the murine beta interferon promoter and regulates its transcriptional capacity with a dual activator/repressor role. J Virol 77: 2903-2914, 2003.
55. Xu H, Okamoto A, Ichikawa J, Ando T, Tasaka K, Masuyama K, Ogawa H, Yagita H, Okumura K, and Nakao A. TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF. Biochem Biophys Res Commun 318: 422-427, 2004.
56. Yeh TS, Lin YM, Hsieh RH, and Tseng MJ. Association of transcription factor YY1 with the high molecular weight Notch complex suppresses the transactivation activity of Notch. J Biol Chem 278: 41963-41969, 2003.